Vysis, Inc.
Records under this name other than patents Vysis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,351,912 | Detection of high grade dysplasia in cervical cells Formerly held Lapsed on the fee record Ended Jul 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2023 | From the USPTO record |
| US 8,043,805 | Detection of high grade dysplasia in cervical cells Formerly held Term ended Term ended Jul 12, 2023 · From the USPTO record | Term ended | Term ended Jul 12, 2023 | From the USPTO record |
| US 7,998,678 | Methods for the Detection of Lung Cancer Formerly held Term ended Term ended Feb 20, 2022 · Medium confidence | Term ended | Term ended Feb 20, 2022 | Medium confidence |
| US 8,594,944 | Method and/or system for analyzing biological samples using a computer system Lapsed on the fee record Ended Nov 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2021 | From the USPTO record |
| US 7,517,645 | Detection of high grade dysplasia in cervical cells Formerly held Lapsed on the fee record Ended Apr 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2021 | From the USPTO record |
| US 6,905,823 | Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers Formerly held Term ended Term ended Feb 21, 2020 · Medium confidence | Term ended | Term ended Feb 21, 2020 | Medium confidence |
| US 6,482,589 | Nucleic acid probes for the detection of genital mycoplasmas Term ended Term ended Nov 19, 2019 · From the USPTO record | Term ended | Term ended Nov 19, 2019 | From the USPTO record |
| US 9,260,758 | Cellular arrays and methods of detecting and using genetic disorder markers Formerly held Term ended Term ended Oct 28, 2019 · From the USPTO record | Term ended | Term ended Oct 28, 2019 | From the USPTO record |
| US 9,284,610 | Cellular arrays and methods of detecting and using genetic disorder markers Formerly held Term ended Term ended Oct 28, 2019 · From the USPTO record | Term ended | Term ended Oct 28, 2019 | From the USPTO record |
| US 6,194,563 | Solid phase nucleic acid labeling by transamination Formerly held Term ended Term ended Mar 26, 2019 · From the USPTO record | Term ended | Term ended Mar 26, 2019 | From the USPTO record |